Ventas Inc (VTR) has seen a mix of insider activity, with Director Walter Rakowich, SVP, Chief Accounting Officer Gregory Liebbe, and EVP and CFO Robert Probst reportedly selling shares. However, certain entities such as Mitsubishi UFJ Asset Management Co. Ltd, Victory Capital Management Inc., and Principal Financial Group Inc. are holding substantial stock. Several financial institutions like Merit Financial Group LLC and BNP Paribas Financial Markets are increasing their position. Meanwhile, some like Truist Financial Corporation and Swiss National Bank reduced their shares. Favorable analyst estimates have seen Ventas' (NYSE:VTR) price target increased to $51.00 by Scotiabank, with a general consensus of "moderate buy". The company has closed on the Wexford Life Sciences Real Estate deal, declared quarterly dividends, met Q3 FFO estimates, reported an increase in same-store NOI, and issued FY24 earnings guidance. However, the company has also faced allegations of underperformance and is subject to an investigation by Kaskela Law LLC. Ventas' Q2 results surpassed expectations with increased same-store NOI, and it announced leadership transitions, dividend declarations, and plans for redevelopment.
Ventas VTR News Analytics from Sun, 24 Apr 2022 07:00:00 GMT to Thu, 16 May 2024 23:01:55 GMT -
Rating 5
- Innovation -1
- Information 8
- Rumor 4
